References
- Bishop P. M. F., Borell U., Diczfalusy E., Tillinger K.-G. Effect of dydrogesterone on human endometrium and ovarian activity. Acta Endocrinol (Kbh) 1962; 40: 203
- Cullberg J. Mood changes and menstrual symptoms with different gestagen/estrogen combinations. Acta Psychiatr Scand Suppl 1972; 236
- Fairweather D. V. I. Duphastone in dysmenorrhea. J Obstet Gynaecol Br Commonw 1965; 72: 193
- Henzl M. R., Buttram V., Segre E. J. R., Bessler S. The treatment of dysmenorrhea with naproxen sodium. A report on two independent double-blind trials. Am J Obstet Gynecol 1977; 127: 818
- Lundström V., Gréen K. Endogenous levels of prostaglandin F2α and its main metabolites in plasma and endometrium of normal and dysmenorrheic women. Am J Obstet Gynecol 1978; 130: 640
- Lundström V. Treatment of primary dysmenorrhea with prostaglandin synthetase inhibitors – a promising therapeutic alternative. Acta Obstet Gynecol Scand 1978; 57: 421
- Matthews A. E. B., Clarke J. E. F. Double-blind trial of a sequential oral contraceptive (Sequens) in the treatment of dysmenorrhea. Br J Obstet Gynaecol 1968; 75: 1117
- Nakano R., Takomura H. Treatment of functional dysmenorrhea: A double-blind study. Acta Obstet Gynaecol Jap 1971; 18: 41
- Sturgis S. H., Taymor M. L. Progress in Gynecology. Grune & Stratton, New York 1970
- Weinberg C. H. Enovid for control of dysmenorrhea. Proc. Symposium on Enovid, part II 1959; 55: 7